readthroughSign in
CompanyPLXNYSEHackensack, NJ

Protalix BioTherapeutics, Inc.

Protalix develops recombinant enzyme replacement therapies for rare diseases using plant cell-based expression.

10-QNov 10Latest SEC filing
Nov 10Latest story